Thermo Fisher Scientific announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company’s Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics. The new center brings together advanced bioproduction capabilities and hands-on collaboration to help customers accelerate process development and bring transformative therapies to patients faster. The facility demonstrates Thermo Fisher’s continued commitment to empowering customers as a trusted innovation partner.
The BDC features 4,000 square feet of laboratory and training space to support customers in developing biologics, including vaccines and cell and gene therapies. Customers will experience Thermo Fisher’s complete, end-to-end bioproduction workflow of integrated, scalable solutions – including media, cell line development, single-use systems, chromatography, filtration, purification and analytics – that can unlock productivity gains and reduce time to market.
Onsite bioprocess specialists provide hands-on demonstrations, training and technical consulting. Experts work directly with customers to test and refine processes, validate concepts and address complex challenges to help them move from development to scalable production with greater speed and confidence.
“Our new Bioprocess Design Center brings together Thermo Fisher’s experts and customers to tackle some of the most complex challenges in bioprocessing, demonstrating how collaboration and shared innovation can accelerate therapeutic development and help deliver life-changing therapies to patients faster,” said Daniella Cramp, senior vice president and president, BioProduction and Customer Excellence at Thermo Fisher Scientific. “By creating a space where customers can work side by side with our scientists and engineers, we can help translate innovative ideas into scalable solutions that advance biologics development and manufacturing for customers across the United States.”
“Companies like Thermo Fisher Scientific are choosing Massachusetts because of our world-renowned life sciences sector, and we are proud to partner with them as they continue to grow and invest in our state,” said Governor Maura Healey. “This new Bioprocess Design Center will accelerate cutting-edge research, strengthen our economy, and create new jobs for workers across our state. Massachusetts continues to lead the nation in life sciences because we invest in innovation, support our workforce, and partner with companies that are delivering the next generation of life-saving therapies.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!